Capstone Investment Advisors LLC Purchases New Shares in LifeStance Health Group, Inc. $LFST

Capstone Investment Advisors LLC acquired a new position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST) in the second quarter, according to its most recent disclosure with the SEC. The firm acquired 51,686 shares of the company’s stock, valued at approximately $554,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Larson Financial Group LLC raised its position in LifeStance Health Group by 19,952.6% in the fourth quarter. Larson Financial Group LLC now owns 3,810 shares of the company’s stock worth $27,000 after acquiring an additional 3,791 shares in the last quarter. KBC Group NV purchased a new position in LifeStance Health Group in the first quarter valued at about $29,000. EverSource Wealth Advisors LLC lifted its position in shares of LifeStance Health Group by 359.1% during the 1st quarter. EverSource Wealth Advisors LLC now owns 6,909 shares of the company’s stock valued at $44,000 after acquiring an additional 5,404 shares during the period. PNC Financial Services Group Inc. lifted its position in shares of LifeStance Health Group by 615.3% during the 1st quarter. PNC Financial Services Group Inc. now owns 9,285 shares of the company’s stock valued at $59,000 after acquiring an additional 7,987 shares during the period. Finally, Assetmark Inc. boosted its stake in shares of LifeStance Health Group by 17.0% during the 1st quarter. Assetmark Inc. now owns 9,419 shares of the company’s stock worth $60,000 after acquiring an additional 1,367 shares in the last quarter. 85.50% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at LifeStance Health Group

In related news, CTO Vukasin Paunovich sold 44,394 shares of LifeStance Health Group stock in a transaction on Monday, August 10th. The shares were sold at an average price of $10.85, for a total transaction of $481,674.90. Following the transaction, the chief technology officer owned 247,446 shares in the company, valued at approximately $2,684,789.10. The trade was a 15.21% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, major shareholder Tpg Gp A, Llc sold 13,643,207 shares of LifeStance Health Group stock in a transaction on Monday, August 10th. The stock was sold at an average price of $10.62, for a total transaction of $144,890,858.34. Following the sale, the insider directly owned 98,101,407 shares in the company, valued at $1,041,836,942.34. This trade represents a 12.21% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 14,629,850 shares of company stock worth $154,952,012 over the last 90 days. Company insiders own 3.50% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the company. Canaccord Genuity Group raised their price objective on LifeStance Health Group from $11.00 to $13.00 and gave the company a “buy” rating in a research note on Tuesday, July 21st. The Goldman Sachs Group assumed coverage on LifeStance Health Group in a research report on Friday, June 5th. They issued a “neutral” rating and a $9.00 price target for the company. BTIG Research lifted their price target on LifeStance Health Group from $16.00 to $18.00 and gave the stock a “buy” rating in a research note on Wednesday, August 19th. Zacks Research lowered shares of LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 13th. Finally, Barclays increased their price objective on shares of LifeStance Health Group from $9.00 to $13.00 and gave the company an “overweight” rating in a research note on Tuesday, July 14th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $12.38.

LifeStance Health Group Stock Up 0.1%

Shares of NASDAQ:LFST opened at $12.31 on Friday. The company has a quick ratio of 1.38, a current ratio of 1.38 and a debt-to-equity ratio of 0.18. The company has a market capitalization of $4.77 billion, a P/E ratio of 94.70 and a beta of 1.14. LifeStance Health Group, Inc. has a 52-week low of $4.77 and a 52-week high of $12.97. The stock’s fifty day simple moving average is $11.19 and its 200-day simple moving average is $8.60.

LifeStance Health Group (NASDAQ:LFST) last announced its earnings results on Thursday, August 6th. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.03. The firm had revenue of $435.35 million during the quarter, compared to the consensus estimate of $414.58 million. LifeStance Health Group had a net margin of 3.19% and a return on equity of 3.39%. The firm’s revenue for the quarter was up 26.1% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.01) EPS. As a group, equities research analysts forecast that LifeStance Health Group, Inc. will post 0.16 earnings per share for the current fiscal year.

LifeStance Health Group Profile

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.